VisionPoint Advisory Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VisionPoint Advisory Group's GILD Position: Q3 2026 in Review
VisionPoint Advisory Group increased its Gilead Sciences (GILD) stake by 0.52% in Q3 2026, buying an estimated $4.35K and bringing the position to 6,013 shares worth $896K. The position accounts for 0.14% of the portfolio, ranked #158.
VisionPoint Advisory Group first reported a position in GILD in Q4 2023 and has held it in 8 quarters since. 2,330 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- VisionPoint Advisory Group held 6,013 shares of Gilead Sciences worth $896K as of Q3 2026.
- VisionPoint Advisory Group bought 31 Gilead Sciences shares in Q3 2026, an estimated $4.35K.
- Gilead Sciences made up 0.14% of VisionPoint Advisory Group's portfolio in Q3 2026, its #158 holding.
- VisionPoint Advisory Group first reported a position in Gilead Sciences in Q4 2023 and has held it in 8 quarters since.
- 2,330 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on VisionPoint Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.